Even as there is still question hanging over the efficacy of hydroxychloroquine (HCQ) as medication for Covid-19, Swiss drug maker Novartis announced trials to evaluate use of HCQ for the treatment of hospitalised patients.from Industry-Economic Times
Read The Rest:economictimes...
